Can You Get Moles on Your Labia? What You Should Know

Moles can and do appear on the labia, just as they can develop on virtually any skin or mucosal surface where pigment-producing cells exist. The vulvar area, including both the labia majora and labia minora, contains melanocytes, and these cells can form the same benign growths seen elsewhere on the body. What makes labial moles worth paying attention to is that a small subset look unusual under a microscope, and the vulva is also one of the less common but well-documented sites for melanoma. Understanding the difference between a harmless mole, a benign-but-odd-looking one, and a genuinely dangerous lesion matters more here than on, say, your forearm, because the area is harder to self-examine and people are far less likely to bring it up with a doctor.

Why Moles Form on the Labia

Melanocytes, the cells responsible for skin pigmentation, are distributed across nearly all skin surfaces, including the genital area. When these cells cluster together in the top layers of the skin, you get a mole (or nevus). The labia majora, which are covered with hair-bearing skin similar to the rest of the body, develop moles in much the same way your arm or back does. The labia minora have a different tissue type, closer to mucous membrane, but melanocytes are present there too. Moles on the labia minora tend to be flatter and more lightly pigmented, while those on the labia majora more closely resemble typical skin moles.

Most vulvar moles are entirely benign. In one large dermoscopic study of pigmented vulvar lesions, about a third of the lesions examined were melanocytic (moles or mole-like growths), and the majority were found in younger women.¹ The rest were nonmelanocytic pigmented spots, such as melanosis or seborrheic keratoses. So if you notice a small, stable brown spot on your labia, it is more likely to be benign than not. That said, genital moles deserve a closer look than you might give a mole on your leg, because of a few quirks specific to the area.

Atypical Genital Nevi and Why They Fool Pathologists

One of the most interesting things about labial moles is that a specific subtype can look alarmingly abnormal under a microscope while still being completely harmless. These are called atypical melanocytic nevi of the genital type, sometimes abbreviated AMNGT. They tend to show up in premenopausal women, often in their twenties, and they have features that pathologists associate with melanoma in other body sites: irregular cell nests, some spread of pigmented cells upward through the skin layers, and moderate to severe cellular irregularity.²

Despite all that, these lesions behave in a benign way. In a study of 56 such cases followed for a median of three and a half years, only one recurred, and that was after incomplete removal.² Another series of six AMNGT cases in women with a median age of 21 found no recurrences after a median follow-up of over ten years.³ The consensus in dermatopathology is that these nevi are not precursors to melanoma and do not require aggressive treatment beyond excision when diagnosis is uncertain.⁴

This matters for you as a patient because if a biopsy of a labial mole comes back with language about “atypical” or “dysplastic” features, it does not necessarily mean cancer. These genital-specific nevi are a recognized entity, and an experienced dermatopathologist will distinguish them from melanoma. The key features that separate AMNGT from melanoma include symmetry of the lesion, well-defined lateral borders, and a mature-looking deeper component without abnormal cell division.³ If your biopsy report is ambiguous, asking whether the pathologist is experienced with genital melanocytic lesions is a reasonable step.

Where on the Labia Moles Tend to Appear

Location within the vulva varies by lesion type. Common moles and dysplastic nevi (the kind that look somewhat irregular but aren’t specific to the genital area) tend to favor the labia majora, the outer, hair-bearing folds. Atypical genital nevi, by contrast, are more often found on the labia minora or in the clitoral region.⁵ This distribution probably reflects differences in the tissue type and the behavior of melanocytes in mucosal versus hair-bearing skin.

For practical purposes, this means any pigmented spot on the labia minora or near the clitoris warrants a closer look than one on the labia majora, not because it is more likely to be dangerous, but because the lesions that arise in those areas can be harder to evaluate visually and are more likely to have the confusing microscopic features described above.

Vulvar Melanosis Is Not a Mole

Not every dark patch on the labia is a mole. Vulvar melanosis, also called vulvar melanotic macules, refers to flat areas of increased pigmentation that result from overactive melanocytes rather than clustered ones. These are the genital equivalent of a freckle, and they are the most common pigmented finding in the vulvar area. In a cohort of 129 women with vulvar melanosis, the most frequent location was the labia minora, found in about 43% of cases, followed by the labia majora in about 26%.⁶

What can alarm people about melanosis is that these patches sometimes change. In roughly 30% of cases in that same cohort, the lesions grew larger or shifted in color after initial evaluation, though they eventually stabilized.⁶ This kind of change would be a red flag on other parts of the body, where the “ABCDE” rules for melanoma screening emphasize evolving size and color. On the vulva, melanotic macules are more dynamic, and change alone does not indicate melanoma. That said, a new or changing pigmented spot still deserves evaluation by a clinician who can determine whether it is simple melanosis or something that needs a biopsy.

Dermoscopic examination (a handheld magnification device used by dermatologists) can help sort these out. Vulvar melanosis tends to show a diffuse brown pigmentation pattern, sometimes with a ring-like pattern that is specific to melanosis and not seen in moles or melanoma.⁷ Nevi, on the other hand, more commonly show a globular or cobblestone pattern.¹

When to Worry About Melanoma

Vulvar melanoma is rare, but it is the second most common type of vulvar cancer, accounting for roughly 5 to 10% of all vulvar malignancies.⁸ Compared with melanoma on sun-exposed skin, vulvar melanoma carries a worse prognosis and tends to respond less well to immunotherapy.⁹ Part of the reason for poorer outcomes is that the lesion is often diagnosed late, because the area is not regularly inspected and because patients and providers alike can be reluctant to address genital symptoms.

Dermoscopy provides the strongest noninvasive clue. In the vulvar setting, melanomas consistently show a multicomponent pattern, meaning a chaotic mix of structures that don’t fit any single category.¹ Features like a blue-white veil and irregular dots, when seen on dermoscopy of a genital lesion, are associated with atypical genital nevi and should prompt a biopsy to rule out melanoma.⁷

For your own self-monitoring, the signs that should send you to a doctor include any new pigmented spot that is asymmetric, has irregular or blurred borders, shows multiple colors (especially black, blue, or gray alongside brown), is larger than about six millimeters, or is changing rapidly. On the vulva, these criteria are less reliable than on regular skin, so the most practical advice is simpler: if you notice a new or changing dark spot on your labia that you have not had evaluated, bring it up at your next appointment or make one specifically for it.

The Genetic Profile of Vulvar Melanoma

If a labial mole does turn out to be melanoma, its molecular biology differs from the melanoma you hear about most often. Skin melanomas on sun-exposed sites are frequently driven by BRAF mutations, which is why targeted BRAF-inhibitor drugs have been a major breakthrough for advanced melanoma. Vulvar and vaginal melanomas have a different mutation landscape. The most distinctive feature is a high rate of KIT mutations: about 22% of vulvar and vaginal melanomas carry KIT mutations, compared with only 3% of cutaneous melanomas.¹⁰ NRAS mutations have also been reported in vulvar melanoma cases.¹¹

These differences matter for treatment. A KIT-mutated melanoma can be targeted with imatinib, a drug originally developed for certain leukemias. NRAS-mutated tumors may respond to MEK inhibitors. The point is that vulvar melanoma is not simply “melanoma in an unusual place.” It is a molecularly distinct cancer subtype, and treating it effectively depends on molecular testing of the tumor, not just staging it the same way as a skin melanoma.

How Biopsy Works on the Vulva

If a clinician decides a pigmented lesion on your labia needs further evaluation, the standard next step is a biopsy. On the vulva, this typically involves a punch biopsy or a shave biopsy performed under local anesthesia. For pigmented lesions, the biopsy should include the edge of the lesion so the pathologist can assess the border and determine whether the growth pattern is contained or spreading. Lesions suspected to be cancerous should be biopsied deeply enough to assess how far into the skin they extend.¹²

If a lesion is large or has an uneven appearance, multiple biopsies from different areas may be needed, because a single sample might miss the most abnormal section. Recovery from a vulvar biopsy is usually straightforward. The site is small, and most people experience mild soreness for a few days. The tissue is then examined by a pathologist, ideally one familiar with the peculiarities of genital melanocytic lesions, since the atypical features described earlier can lead to misdiagnosis if the pathologist is not accustomed to seeing them.

Hormonal Factors and Pigment Changes

Hormonal shifts can influence pigmentation in the vulvar area. In the vulvar melanosis cohort mentioned earlier, about two-thirds of women were premenopausal, and a similar proportion had received some form of hormone therapy.⁶ Pregnancy is another period when vulvar pigmentation can darken noticeably, which is usually harmless. However, there has been longstanding concern that the hormonal and immunological shifts of pregnancy could affect pre-existing melanoma, potentially accelerating its progression.¹³

This does not mean pregnancy causes vulvar melanoma or that you should panic over darkening labia during pregnancy. It means that if you already have a known atypical or undiagnosed pigmented vulvar lesion, it is worth having it evaluated before or during pregnancy. Any new, rapidly growing dark spot on the vulva during pregnancy should be assessed promptly rather than attributed to normal hormonal changes.

Genital Moles in Children

Genital moles are not exclusive to adults. In a pediatric dermatology practice, genital nevi were found in about 3.5% of children and adolescents evaluated for moles, with a slight male predominance. Nearly two-thirds of those moles appeared before age two.¹⁴ Under dermoscopy, these childhood genital moles overwhelmingly showed a benign globular pattern, and most underwent gradual changes in size, color, and texture over time, which is typical of growing children’s nevi and not a sign of malignancy.

Parents who discover a mole on their child’s genital area are understandably worried, but the evidence suggests these behave like moles elsewhere on the body. Monitoring for rapid growth, color shifts beyond normal developmental changes, or bleeding is reasonable, and a pediatric dermatologist can evaluate any mole that looks unusual.

Why People Avoid Talking About Vulvar Lesions

One of the biggest obstacles to getting a labial mole checked is embarrassment. Research on vulvar skin conditions consistently finds that shame and cultural taboos around the genitalia delay diagnosis, sometimes by years. A qualitative study of women with vulvar skin conditions found that the shame was profound enough to prevent them from disclosing symptoms at all, leading directly to delayed diagnosis and disease progression.¹⁵

The problem runs in both directions. A survey of healthcare professionals found that the top barriers to diagnosing vulvar conditions included not only patients being embarrassed to raise the topic but also clinicians’ own lack of knowledge and unclear diagnostic criteria.¹⁶ This is especially relevant for older women, who may have grown up in an era when discussing genital anatomy was considered deeply taboo.¹⁷

The practical takeaway is blunt: you do not need to wait for a gynecological exam to bring up a pigmented spot on your labia. You can mention it to a dermatologist, a primary care provider, or a gynecologist. Any of them can take a look and decide whether further evaluation is needed. If you feel dismissed, requesting a dermoscopic exam or a referral to a specialist experienced with vulvar dermatology is entirely appropriate. The worst thing to do with a changing pigmented lesion in this area is to ignore it because the conversation feels uncomfortable.

Practical Self-Examination Tips

Unlike a mole on your arm, a mole on the labia is not something you see every day. Periodic self-examination using a handheld mirror in good lighting is the simplest way to keep track of what is normal for you. You are looking for new spots you have not noticed before, changes in existing spots (darkening, growing, developing irregular borders), and any spot that bleeds, itches persistently, or feels different from the surrounding tissue.

There is no formal screening guideline for vulvar melanoma in the general population because it is so uncommon. But gynecological exams do include a visual inspection of the vulva, and asking your provider to comment specifically on any pigmented spots during that exam costs nothing and takes seconds. If you have a known mole in the area, photographing it periodically (even on your phone, in consistent lighting) gives you and your clinician a baseline for comparison. Melanosis, atypical nevi, and melanoma all exist on the same anatomic real estate, and the only way to tell them apart with certainty is a trained eye and, when needed, a biopsy. Self-awareness is the first step toward getting that expert evaluation when it matters.